Global Exosome Technologies Market Size and Forecast 2024-2033|AEGLE Therapeutics, Aruna Bio Inc., Carmine Therapeutics Inc., Exosome Diagnostics Inc., Creative Biolabs Inc

The Exosome Technologies Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Exosome Technologies Market:

https://www.thebusinessresearchcompany.com/report/exosome-technologies-global-market-report

According to The Business Research Company’s Exosome Technologies Global Market Report 2024, The exosome technologies market size has grown exponentially in recent years. It will grow from $0.06 billion in 2023 to $0.07 billion in 2024 at a compound annual growth rate (CAGR) of 26.7%. The growth in the historic period can be attributed to therapeutic advancements, isolation technique developments, research funding boost, regenerative medicine exploration, clinical trials inception.

The exosome technologies market size is expected to see exponential growth in the next few years. It will grow to ” $0.18 billion in 2028 at a compound annual growth rate (CAGR) of 27.0%. The growth in the forecast period can be attributed to regulatory progress, biomedical engineering innovations, clinical trials proliferation, regenerative medicine development, nanotechnology integration growth. Major trends in the forecast period include therapeutic advancements, diagnostic applications, nanotechnology integration, research funding surge, development of isolation techniques.

The rising prevalence of chronic diseases is expected to drive the growth of the exosome technologies market. Chronic disease refers to a health condition or disease that is persistent or long-lasting in its effects, usually lasting for three months or longer, and may get worse over time. The rising prevalence of chronic diseases demands exosome technologies that offer potential uses such as identifying disease-specific biomarkers and monitoring disease progression using exosome cargo analysis, targeted drug delivery, and immune modulation in chronic conditions. For instance, in January 2023, according to the National Center for Biotechnology Information (NCBI), a US-based international resource for the scientific research community, the number of individuals aged 50 years and older having one or more chronic illnesses is projected to rise by 99.5%, reaching 142.66 million by 2050, up from 71.522 million in 2020 in the United States. Furthermore, in July 2022, according to the Australian Institute of Health and Welfare (AIHW), an Australia-based government agency, approximately 47%, or 11.6 million individuals in Australia, were estimated to be affected by at least one of the ten chosen chronic ailments. Therefore, the rising prevalence of chronic diseases is expected to propel the growth of the exosome technologies market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=10705&type=smp

The exosome technologies market covered in this report is segmented –

1) By Exosome Type: Loaded Cargos, Non-Cargo

2) By Cell Source: HEK293 Cells, Mesenchymal Stem Cells (MSCs), Platelets, Erythrocytes, Natural Killer Cells, Other Cell Sources

3) By Application: Therapeutics, Diagnostics

4) By End-Users: Health Care Providers, Pharmaceutical And Biotechnology Companies, Other End-Users

Advanced exosome characterization technologies are a key trend gaining popularity in the exosome technology market. Companies operating in the exosome technology market are adopting new technologies to sustain their position in the market. For instance, in August 2022, Creative Biolabs Inc., a US-based biotech company, launched a platform named NanosightTM for exosome characterization using Nanosight technology. Nanosight is a nanoparticle tracking analysis (NTA) technique that allows for the visualization and quantification of exosomes based on their size and concentration. By utilizing this platform, Creative Biolabs aims to provide researchers with advanced tools for the characterization and analysis of exosomes, facilitating their understanding of exosome properties and functions.

The exosome technologies market report table of contents includes:

1. Executive Summary

2. Exosome Technologies Market Characteristics

3. Exosome Technologies Market Trends And Strategies

4. Exosome Technologies Market – Macro Economic Scenario

5. Global Exosome Technologies Market Size and Growth

26. South America Exosome Technologies Market

27. Brazil Exosome Technologies Market

28. Middle East Exosome Technologies Market

29. Africa Exosome Technologies Market

30. Exosome Technologies Market Competitive Landscape And Company Profiles

Top Major Players: